Login/Register

Vectura Group Share Price. VEC Share Price. Vectura Group Stock Quote. Vectura Group Charts.

VECTURA GROUP QUOTE

Vectura Group (VEC)

100.30

Chg.%: 0.0999% Chg.: 0.1000 Time: 16:34

Annual Report

► Detailed Vectura Group Share Price Changes
Last 1 week 1 month 3 months 6 months 1 year
Change 0.1000 -0.0360 -0.1160 -0.1510 -0.6180 -0.4090
Change % 0.0999 -3.4682 -10.3757 -13.0963 -38.1481 -28.9865
Volume 704,283 8,756,136 33,484,300 73,977,720 226,690,640 429,098,720
► Chart
► Detailed Price Data
Data Value
Price 100.30
Update Time 16:34
Open 100.20
Close 100.10
Data Value
Change Today 0.1000
Percent Change 0.0999
High 100.40
Low 99.20
► Related News
Monday broker round-up

Monday broker round-up

(ShareCast News) - Ricardo: Berenberg downgrades to Sell with a target price of 680p. Admiral: Deutsche Bank upgrades to Hold with a target price of 1880p. Barclays: HSBC reiterates Buy with a target... [more]

Vectura's growing recurring revenues cushion blow of bigger loss

Vectura's growing recurring revenues cushion blow of bigger loss

(ShareCast News) - Respiratory drug device specialist Vectura reported a wider first-half loss as its revenues moved towards recurring sources amid fewer milestone payments. On revenue of £78.8m in th... [more]

Vectura awaits more details from FDA over Advair

Vectura awaits more details from FDA over Advair

(ShareCast News) - Drug delivery specialist Vectura has noted comments on Thursday morning by Hikma, its partner on the development of a generic version of the Advair Diskus asthma treatment. Followin... [more]

Vectura signs global development agreement with Dynavax

Vectura signs global development agreement with Dynavax

(ShareCast News) - Wiltshire-based pharmaceuticals business Vectura Group announced it had signed an exclusive agreement with NASDAQ listed company Dynavax Technologies. The agreement with Dynavax, a ... [more]

GSK applies to widen indications for combined asthma drug

GSK applies to widen indications for combined asthma drug

(ShareCast News) - GlaxoSmithKline has submitted its Relvar Ellipta asthma drug to European regulators for approval as a extended once-daily treatment. Earlier in the year a huge study showed the drug... [more]

► Star Ratings

Data Sector Market
Value 4.77272720325 4.77272720325 4.77272720325 4.77272720325 4.77272720325 4.677230072 4.677230072 4.677230072 4.677230072 4.677230072
Income 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5
Price Trend 1.19047622675 1.19047622675 1.19047622675 1.19047622675 1.19047622675 0.39136619575 0.39136619575 0.39136619575 0.39136619575 0.39136619575
Growth 2.5409836055 2.5409836055 2.5409836055 2.5409836055 2.5409836055 1.68300657275 1.68300657275 1.68300657275 1.68300657275 1.68300657275

► What The Brokers Say

Strong Buy 6.00
Buy 0.00
Neutral 2.00
Sell 0.00
Strong Sell 1.00
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

NASDAQ 100 Top Risers

Name Last Chg.% Time
O'Reilly Automotive Inc. 209.59 3.62 22:35
Liberty Interactive Corporation QVC Group 23.76 2.72 22:34
Paychex Inc. 59.75 2.68 22:35
Seagate Technology Plc 33.57 2.60 22:49
Lam Research Corp. 176.73 2.58 22:53

NASDAQ 100 Top Fallers

Name Last Chg.% Time
Tesla Inc 351.09 -4.20 23:10
Incyte Corp. 110.85 -3.65 23:04
Mattel Inc. 14.52 -3.20 23:01
NetEase Inc. Ads 271.61 -2.16 22:34
Kraft Heinz Co. 77.52 -1.89 22:35